Articles by Sergio Garcia - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Sergio Garcia

Sergio Garcia

cochair of life sciences group

CoChair of life sciences group, and partner, corporate and intellectual property group, at Fenwick & West LLP, Embarcadero Center West.

Articles
How Small Biotechs Should Protect Their Interests During Mergers and Acquisitions
January 1, 2008

Strategic alliances and partnering deals were a big biotech news story during 2006—with deal values setting an all time record of over $23 billion for the year. The strategic partnering trend continues during 2007 and in this column we present some frequently asked questions and answers about the merger and acquisition (M&A) activity in the life sciences sector.

IP Briefs: IP Due Diligence: Key to Success in M&A Transactions
March 1, 2007

Although IP due diligence is relevant to virtually any transaction between biotech companies, a detailed investigation into IP assets is particularly critical to M&A transactions.

Legal Forum: Putting the "Co" in Development and Promotion: The New Biotech-Pharma Collaborations
August 1, 2006

Wyeth today relies on biotech product revenue to drive approximately 25% of its revenues.

ADVERTISEMENT

ADVERTISEMENT

Click here